Burk KH - Search Results

1

Expression of infectious viral particles by primary chimpanzee hepatocytes isolated during the acute phase of non-A, non-B hepatitis.

Jacob JR, Burk KH, Eichberg JW, Dreesman GR, Lanford RE. Jacob JR, et al. Among authors: burk kh. J Infect Dis. 1990 Jun;161(6):1121-7. doi: 10.1093/infdis/161.6.1121. J Infect Dis. 1990. PMID: 2111839

2

Expression and characterization of hepatitis B virus precore-core antigen in E. coli.

Lanford RE, Notvall LM, Dreesman GR, Harrison CR, Lockwood D, Burk KH. Lanford RE, et al. Among authors: burk kh. Viral Immunol. 1987;1(2):97-109. doi: 10.1089/vim.1987.1.97. Viral Immunol. 1987. PMID: 3334704

3

Detection of non-A, non-B hepatitis antigen by immunocytochemical staining.

Burk KH, Oefinger PE, Dreesman GR. Burk KH, et al. Proc Natl Acad Sci U S A. 1984 May;81(10):3195-9. doi: 10.1073/pnas.81.10.3195. Proc Natl Acad Sci U S A. 1984. PMID: 6203116 Free PMC article.

4

Long-term sequelae of non-A, non-B hepatitis in experimentally infected chimpanzees.

Burk KH, Dreesman GR, Cabral GA, Peters RL. Burk KH, et al. Hepatology. 1984 Sep-Oct;4(5):808-16. doi: 10.1002/hep.1840040502. Hepatology. 1984. PMID: 6148298

5

Ultrastructural changes and virus-like particles localized in liver hepatocytes of chimpanzees infected with non-A, non-B hepatitis.

Burk KH, Cabral GA, Dreesman GR, Peters RL, Alter HJ. Burk KH, et al. J Med Virol. 1981;7(1):1-19. doi: 10.1002/jmv.1890070102. J Med Virol. 1981. PMID: 6787170 No abstract available.

6

Association of human hepatocellular membrane fusions with non-A, non-B hepatitis.

Cabral GA, Burk K, Lattyak M, Carithers RL. Cabral GA, et al. Virchows Arch B Cell Pathol Incl Mol Pathol. 1986;51(3):227-34. doi: 10.1007/BF02899032. Virchows Arch B Cell Pathol Incl Mol Pathol. 1986. PMID: 2874655

7

Hepatitis C Care Cascades for 3 Populations at High Risk: Low-income Trans Women, Young People Who Inject Drugs, and Men Who Have Sex With Men and Inject Drugs.

Facente SN, Patel S, Hecht J, Wilson E, McFarland W, Page K, Vickerman P, Fraser H, Burk K, Morris MD. Facente SN, et al. Clin Infect Dis. 2021 Sep 15;73(6):e1290-e1295. doi: 10.1093/cid/ciab261. Clin Infect Dis. 2021. PMID: 33768236 Free PMC article.

8

Progress toward closing gaps in the hepatitis C virus cascade of care for people who inject drugs in San Francisco.

Mirzazadeh A, Chen YH, Lin J, Burk K, Wilson EC, Miller D, Veloso D, McFarland W, Morris MD. Mirzazadeh A, et al. PLoS One. 2021 Apr 2;16(4):e0249585. doi: 10.1371/journal.pone.0249585. eCollection 2021. PLoS One. 2021. PMID: 33798243 Free PMC article.

9

Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019.

Facente SN, Grinstein R, Bruhn R, Kaidarova Z, Wilson E, Hecht J, Burk K, Grebe E, Morris MD. Facente SN, et al. PLoS One. 2022 May 11;17(5):e0267902. doi: 10.1371/journal.pone.0267902. eCollection 2022. PLoS One. 2022. PMID: 35544483 Free PMC article.

10

Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.

Facente SN, Grebe E, Burk K, Morris MD, Murphy EL, Mirzazadeh A, Smith AA, Sanchez MA, Evans JL, Nishimura A, Raymond HF; End Hep C SF. Facente SN, et al. PLoS One. 2018 Apr 11;13(4):e0195575. doi: 10.1371/journal.pone.0195575. eCollection 2018. PLoS One. 2018. PMID: 29641546 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters